One of the American companies could have infringed a patent for the production of Sputnik V, said the head of the Russian Direct Investment Fund Kirill Dmitriev at a meeting with the president on vaccination against coronavirus.
The head of the RDIF explained that the drug has “very strong patent protection”, since its developers filed the necessary applications earlier than others.
“Perhaps one of the American companies that produce the vaccine is infringing on our patents. We have notified this company, we want to start a dialogue with them,” Dmitriev added.
He stressed that RDIF is not going to demand any money from a US company in the context of a pandemic, but will “take seriously the protection of <…> intellectual rights.”
The issue of the level of patent protection was raised by Vladimir Putin at the meeting. He stressed that Russia offers the transfer of vaccine production technologies, which no one else in the world is doing.
Answering the president, the deputy general director of the Gamaleya Center Denis Logunov noted that the developers had written all the patents and submitted all applications.
Gam-COVID-Vac (Sputnik V trademark) became the world’s first registered vaccine against COVID-19. Its use has already been approved by 55 states with a total population of over 1.4 billion people.